BD announces the FDA approval of Diphenhydramine Hydrochloride Injection, USP, an injectable antihistamine as the first drug to be offered in the BD Simplist ready-to-administer line of prefilled generic injectables. The BD Simplist prefilled injectables are designed to help improve patient care and safety by decreasing the number of steps in the traditional vial and syringe injection sequence, thereby reducing the potential risk of medication error. The individually packaged, prefilled syringes offer easy-to-read labels on each syringe, as well as bar coding for proper identification. Visit BD's website for more information about Diphenhydramine Hydrochloride Injection, USP.